{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:58:56Z","timestamp":1791007136618,"version":"4.1.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.4065\/80.11.1517","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:26:10Z","timestamp":1232760370000},"page":"1517-1527","source":"Crossref","is-referenced-by-count":119,"title":["Adult Acute Lymphoblastic Leukemia"],"prefix":"10.4065","volume":"80","author":[{"given":"Elias J.","family":"Jabbour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Faderl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagop M.","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/80.11.1517_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","article-title":"Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.4065\/80.11.1517_bib2","volume":"Vol 2","year":"1998"},{"key":"10.4065\/80.11.1517_bib3","series-title":"Leukemia","first-page":"145","article-title":"Epidemiology of leukemia: overview of patterns of occurrence","author":"Groves","year":"1996"},{"key":"10.4065\/80.11.1517_bib4","series-title":"Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995","year":"1999"},{"key":"10.4065\/80.11.1517_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.taap.2003.12.028","article-title":"Nongenetic causes of childhood cancers: evidence from international variation, time trends, and risk factor studies","volume":"199","author":"Bunin","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.4065\/80.11.1517_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.taap.2003.12.032","article-title":"Causes of childhood leukaemia and lymphoma","volume":"199","author":"Lightfoot","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.4065\/80.11.1517_bib7","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(86)90616-1","article-title":"Lymphoblastic leukaemia in Siamese twins: evidence for identity [letter]","volume":"2","author":"Pombo de Oliveira","year":"1986","journal-title":"Lancet"},{"key":"10.4065\/80.11.1517_bib8","first-page":"83","article-title":"Familial leukemia [in French]","volume":"65","author":"Schmitt","year":"1978","journal-title":"Bull Cancer"},{"key":"10.4065\/80.11.1517_bib9","series-title":"Hematology of Infancy and Childhood","first-page":"1102","article-title":"Epidemiology of cancer in childhood","author":"Li","year":"1993"},{"key":"10.4065\/80.11.1517_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0022-3476(98)70100-3","article-title":"Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group","volume":"133","author":"Mertens","year":"1998","journal-title":"J Pediatr"},{"key":"10.4065\/80.11.1517_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/adc.85.4.321","article-title":"Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment","volume":"85","author":"Chessells","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.4065\/80.11.1517_bib12","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/1097-0142(19800401)45:7<1675::AID-CNCR2820450725>3.0.CO;2-D","article-title":"Ataxia-telangiectasia and acute lymphoblastic leukemia","volume":"45","author":"Toledano","year":"1980","journal-title":"Cancer"},{"key":"10.4065\/80.11.1517_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/08880019209006400","article-title":"Acute lymphoblastic leukemia and Klinefelter's syndrome","volume":"9","author":"Shaw","year":"1992","journal-title":"Pediatr Hematol Oncol"},{"issue":"suppl 4","key":"10.4065\/80.11.1517_bib14","first-page":"285","article-title":"Acute lymphoblastic leukemia in children with Fanconi anemia [in Polish]","volume":"51","author":"Janik-Moszant","year":"1998","journal-title":"Wiad Lek"},{"key":"10.4065\/80.11.1517_bib15","doi-asserted-by":"crossref","first-page":"12810","DOI":"10.1073\/pnas.96.22.12810","article-title":"Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults","volume":"96","author":"Skibola","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/80.11.1517_bib16","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1073\/pnas.061408298","article-title":"Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia","volume":"98","author":"Wiemels","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/80.11.1517_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.earlhumdev.2004.10.004","article-title":"In utero origins of childhood leukaemia","volume":"81","author":"Greaves","year":"2005","journal-title":"Early Hum Dev"},{"key":"10.4065\/80.11.1517_bib18","first-page":"349","article-title":"An infectious etiology for common acute lymphoblastic leukemia in childhood?","volume":"7","author":"Greaves","year":"1993","journal-title":"Leukemia"},{"key":"10.4065\/80.11.1517_bib19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s002770050539","article-title":"A hypothesis concerning deficiency of sunlight, cold temperature, and influenza epidemics associated with the onset of acute lymphoblastic leukemia in northern Finland","volume":"78","author":"Timonen","year":"1999","journal-title":"Ann Hematol"},{"key":"10.4065\/80.11.1517_bib20","first-page":"336","article-title":"HTLV-1 and associated adult T-cell leukemia\/lymphoma","volume":"7","author":"Mahieux","year":"2003","journal-title":"Rev Clin Exp Hematol"},{"key":"10.4065\/80.11.1517_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0092-8674(87)90556-3","article-title":"Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts","volume":"49","author":"Lombardi","year":"1987","journal-title":"Cell"},{"key":"10.4065\/80.11.1517_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/oxfordjournals.aje.a112230","article-title":"Childhood lymphatic leukemia: prenatal seasonality and possible association with congenital varicella","volume":"103","author":"Vianna","year":"1976","journal-title":"Am J Epidemiol"},{"key":"10.4065\/80.11.1517_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0889-8588(05)70203-3","article-title":"Central nervous system involvement in adult acute lymphocytic leukemia","volume":"15","author":"Cortes","year":"2001","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.4065\/80.11.1517_bib24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"key":"10.4065\/80.11.1517_bib25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1182\/blood.V72.3.873.bloodjournal723873","article-title":"Myeloperoxidase gene expression in blast cells with a lymphoid phenotype in cases of acute lymphoblastic leukemia","volume":"72","author":"Ferrari","year":"1988","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1365-2141.1997.1412956.x","article-title":"Myeloperoxidase gene expression in acute lymphoblastic leukaemia","volume":"97","author":"Serrano","year":"1997","journal-title":"Br J Haematol"},{"key":"10.4065\/80.11.1517_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1096-8652(199602)51:2<147::AID-AJH9>3.0.CO;2-Y","article-title":"Acute lymphoblastic leukemia with myeloperoxidase activity","volume":"51","author":"Wright","year":"1996","journal-title":"Am J Hematol"},{"key":"10.4065\/80.11.1517_bib28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJM197504102921504","article-title":"Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal human thymocytes","volume":"292","author":"McCaffrey","year":"1975","journal-title":"N Engl J Med"},{"key":"10.4065\/80.11.1517_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/10428199609051757","article-title":"Terminal transferase expression in the differential diagnosis of acute leukemias","volume":"22","author":"Meenan","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.4065\/80.11.1517_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/10428190009089432","article-title":"Terminal deoxynucleotidyl transferase expression in acute myelogenous leukemia and myelodysplasia as determined by flow cytometry","volume":"37","author":"Huh","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.4065\/80.11.1517_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5858\/2000-124-0092-TDTNAL","article-title":"Terminal deoxynuleotidyl transferase-negative acute lymphoblastic leukemia","volume":"124","author":"Faber","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.4065\/80.11.1517_bib32","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.11.1517_bib33","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"111","year":"2001"},{"key":"10.4065\/80.11.1517_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1468-0734.2002.00070.x","article-title":"Towards an integrated classification of adult acute lymphoblastic leukemia","volume":"6","author":"Foa","year":"2002","journal-title":"Rev Clin Exp Hematol"},{"key":"10.4065\/80.11.1517_bib35","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"key":"10.4065\/80.11.1517_bib36","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0889-8588(05)70185-4","article-title":"Immunophenotypes in adult acute lymphoblastic leukemia: role of flow cytometry in diagnosis and monitoring of disease","volume":"14","author":"Huh","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.4065\/80.11.1517_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajh.1155","article-title":"Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia","volume":"68","author":"Paredes-Aguilera","year":"2001","journal-title":"Am J Hematol"},{"key":"10.4065\/80.11.1517_bib38","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1182\/blood.V79.3.666.666","article-title":"Flow cytometric assessment of human T-cell differentiation in thymus and bone marrow","volume":"79","author":"Terstappen","year":"1992","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib39","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1309\/08DJ-GPBH-H0VR-RC6F","article-title":"Precursor T-cell acute lymphoblastic leukemia in adults: age-related immunophenotypic, cytogenetic, and molecular subsets","volume":"117","author":"Onciu","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/80.11.1517_bib40","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1182\/blood.V77.8.1681.1681","article-title":"Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells","volume":"77","author":"Gore","year":"1991","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib41","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0889-8588(18)30466-0","article-title":"Immunologic markers in childhood acute lymphoblastic leukemia","volume":"4","author":"Borowitz","year":"1990","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.4065\/80.11.1517_bib42","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1200\/JCO.1998.16.12.3768","article-title":"Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia","volume":"16","author":"Pui","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.11.1517_bib43","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1046\/j.1365-2141.1999.01440.x","article-title":"Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance","volume":"105","author":"Den Boer","year":"1999","journal-title":"Br J Haematol"},{"key":"10.4065\/80.11.1517_bib44","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V92.3.795","article-title":"Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies","volume":"92","author":"Putti","year":"1998","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib45","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/1097-0142(19951101)76:9<1564::AID-CNCR2820760911>3.0.CO;2-1","article-title":"Myeloid markers in adult acute lymphocytic leukemia: correlations with patient and disease characteristics and with prognosis","volume":"76","author":"Preti","year":"1995","journal-title":"Cancer"},{"key":"10.4065\/80.11.1517_bib46","first-page":"64","article-title":"Definition of acute biphenotypic leukemia","volume":"82","author":"Matutes","year":"1997","journal-title":"Haematologica"},{"key":"10.4065\/80.11.1517_bib47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.thj.6200186","article-title":"Is the scoring system an effective clinico-biological tool in myeloid antigen positive adult acute lymphoblastic leukemia? results of a long-term study","volume":"3","author":"Cascavilla","year":"2002","journal-title":"Hematol J"},{"key":"10.4065\/80.11.1517_bib48","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood.V91.11.3995","article-title":"Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia","volume":"91","author":"Faderl","year":"1998","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib49","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1182\/blood.V87.8.3135.bloodjournal8783135","article-title":"Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome: a collaborative study of the Groupe Francais de Cytogenetique Hematologique [published correction appears in Blood. 1996;88:2818]","volume":"87","year":"1996","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib50","first-page":"3983","article-title":"Prospective karyotype analysis in adult acute lymphoblastic leukemia: the Cancer and Leukemia Group B experience","volume":"93","author":"Wetzler","year":"1999","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib51","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1365-2141.1997.d01-2053.x","article-title":"Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA","volume":"96","author":"Secker-Walker","year":"1997","journal-title":"Br J Haematol"},{"key":"10.4065\/80.11.1517_bib52","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1182\/blood-2004-07-2922","article-title":"A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol","volume":"105","author":"Mancini","year":"2005","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib53","first-page":"1897","article-title":"DNA methylation patterns at relapse in adult acute lymphocytic leukemia","volume":"8","author":"Garcia-Manero","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.4065\/80.11.1517_bib54","first-page":"2217","article-title":"DNA methylation of multiple promoter-associated CpG islands in adult acute lymphoblastic leukemia","volume":"8","author":"Garcia-Manero","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.4065\/80.11.1517_bib55","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1182\/blood-2002-08-2466","article-title":"Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia","volume":"101","author":"Shen","year":"2003","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib56","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1182\/blood-2004-03-0954","article-title":"Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia","volume":"104","author":"Roman-Gomez","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib57","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025","article-title":"A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811","volume":"85","author":"Larson","year":"1995","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib58","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V99.3.863","article-title":"Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study","volume":"99","author":"Annino","year":"2002","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib59","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0889-8588(05)70188-X","article-title":"Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL)","volume":"14","author":"G\u00f6kbuget","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.4065\/80.11.1517_bib60","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0889-8588(05)70189-1","article-title":"The Medical Research Council trials in adult acute lymphocytic leukemia","volume":"14","author":"Durrant","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.4065\/80.11.1517_bib61","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0889-8588(05)70191-X","article-title":"Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B","volume":"14","author":"Larson","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"issue":"suppl 2","key":"10.4065\/80.11.1517_bib62","first-page":"148","article-title":"Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87","volume":"6","author":"Schaison","year":"1992","journal-title":"Leukemia"},{"key":"10.4065\/80.11.1517_bib63","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","article-title":"Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"18","author":"Kantarjian","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.11.1517_bib64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1182\/blood.V73.1.57.57","article-title":"Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy","volume":"73","author":"Hussein","year":"1989","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib65","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2141.1989.tb04295.x","article-title":"GIMEMA ALL 0183: a multicentric study on adult acute lymphoblastic leukaemia in Italy","volume":"71","author":"GIMEMA Cooperative Group","year":"1989","journal-title":"Br J Haematol"},{"key":"10.4065\/80.11.1517_bib66","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2002.07.116","article-title":"Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia","volume":"20","author":"Linker","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.11.1517_bib67","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2141.1997.3613175.x","article-title":"Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA","volume":"99","author":"Durrant","year":"1997","journal-title":"Br J Haematol"},{"key":"10.4065\/80.11.1517_bib68","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/sj.leu.2400912","article-title":"Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin","volume":"12","author":"Todeschini","year":"1998","journal-title":"Leukemia"},{"key":"10.4065\/80.11.1517_bib69","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2141.1994.tb04982.x","article-title":"Acute lymphocytic leukaemia in the elderly: characteristics and outcome with the vincristine-adriamycin-dexamethasone (VAD) regimen","volume":"88","author":"Kantarjian","year":"1994","journal-title":"Br J Haematol"},{"key":"10.4065\/80.11.1517_bib70","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/mpo.2950190411","article-title":"Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia","volume":"19","author":"Jones","year":"1991","journal-title":"Med Pediatr Oncol"},{"key":"10.4065\/80.11.1517_bib71","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1964::AID-CNCR27>3.0.CO;2-1","article-title":"Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia","volume":"88","author":"Hurwitz","year":"2000","journal-title":"Cancer"},{"key":"10.4065\/80.11.1517_bib72","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1182\/blood-2002-08-2454","article-title":"Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group","volume":"101","author":"Bostrom","year":"2003","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib73","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1182\/blood.V78.11.2814.2814","article-title":"Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report","volume":"78","author":"Linker","year":"1991","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib74","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF00686263","article-title":"Nation-wide randomized comparative study of doxorubicin, vincristine and prednisolone combination therapy with and without L-asparaginase for adult acute lymphoblastic leukemia","volume":"33","author":"Nagura","year":"1994","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.4065\/80.11.1517_bib75","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1468-0734.2002.00068.x","article-title":"Recent approaches in acute lymphoblastic leukemia in adults","volume":"6","author":"G\u00f6kbuget","year":"2002","journal-title":"Rev Clin Exp Hematol"},{"key":"10.4065\/80.11.1517_bib76","first-page":"567s","article-title":"Hyper-CVAD and rituximab therapy in HIV-negative Burkitt (BL) or Burkitt-like (BLL) leukemia\/lymphoma and mature B-cell acute lymphocytic leukemia (B-ALL) [abstract]","volume":"23","author":"Thomas","year":"2005","journal-title":"ASCO Annual Meeting Proc"},{"key":"10.4065\/80.11.1517_bib77","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0169-409X(03)00110-8","article-title":"Pegaspargase: a review of clinical studies","volume":"55","author":"Graham","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.4065\/80.11.1517_bib78","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1182\/blood.V86.2.444.bloodjournal862444","article-title":"Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial","volume":"86","author":"Ottmann","year":"1995","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib79","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1182\/blood-2003-09-3243","article-title":"Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival","volume":"103","author":"Chiaretti","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib80","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"},{"key":"10.4065\/80.11.1517_bib81","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"10.4065\/80.11.1517_bib82","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.leu.2403167","article-title":"Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients","volume":"18","author":"Kohlmann","year":"2004","journal-title":"Leukemia"},{"key":"10.4065\/80.11.1517_bib83","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/sj.leu.2402412","article-title":"Identification of novel targets for cancer therapy using expression proteomics","volume":"16","author":"Hanash","year":"2002","journal-title":"Leukemia"},{"key":"10.4065\/80.11.1517_bib84","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-134-7-200104030-00011","article-title":"Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications","volume":"134","author":"Santini","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.4065\/80.11.1517_bib85","first-page":"1556","article-title":"A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111","volume":"92","author":"Larson","year":"1998","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib86","first-page":"802a","article-title":"Intensification of induction and consolidation improves only subgroups of adult ALL: analysis of 1200 patients in GMALL Study 05\/93 [abstract]","volume":"98","author":"G\u00f6kbuget","year":"2001","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib87","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.1986.4.12.1732","article-title":"Results of treatment of advanced-stage Burkitt's lymphoma and B cell (sIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine","volume":"4","author":"Murphy","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.11.1517_bib88","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/cncr.20668","article-title":"Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"101","author":"Kantarjian","year":"2004","journal-title":"Cancer"},{"key":"10.4065\/80.11.1517_bib89","first-page":"222","article-title":"Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia: results of a prospective multicenter randomized trial (PETHEMA ALL-89)","volume":"83","author":"Ribera","year":"1998","journal-title":"Haematologica"},{"key":"10.4065\/80.11.1517_bib90","first-page":"425","article-title":"Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB Study","volume":"5","author":"Cuttner","year":"1991","journal-title":"Leukemia"},{"key":"10.4065\/80.11.1517_bib91","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(96)91615-3","article-title":"Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12000 randomised children","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.4065\/80.11.1517_bib92","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1200\/JCO.1988.6.4.583","article-title":"Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia","volume":"6","author":"Cassileth","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.11.1517_bib93","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1182\/blood.V86.6.2091.bloodjournal8662091","article-title":"The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia","volume":"86","author":"Cortes","year":"1995","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib94","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM199307293290504","article-title":"Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia","volume":"329","author":"Mahmoud","year":"1993","journal-title":"N Engl J Med"},{"key":"10.4065\/80.11.1517_bib95","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/mpo.2950140317","article-title":"Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment","volume":"14","author":"Mastrangelo","year":"1986","journal-title":"Med Pediatr Oncol"},{"key":"10.4065\/80.11.1517_bib96","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.V55.2.199.199","article-title":"Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophylaxis","volume":"55","author":"Omura","year":"1980","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib97","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/blood.V72.5.1784.1784","article-title":"Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia","volume":"72","author":"Kantarjian","year":"1988","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib98","first-page":"767","article-title":"Role of allogeneic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission","volume":"14","author":"De Witte","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.4065\/80.11.1517_bib99","first-page":"3394","article-title":"A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors","volume":"5","author":"Glantz","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.4065\/80.11.1517_bib100","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1200\/JCO.1994.12.12.2580","article-title":"Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study","volume":"12","author":"Sebban","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.11.1517_bib101","first-page":"383","article-title":"Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission","volume":"14","author":"Vey","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.4065\/80.11.1517_bib102","doi-asserted-by":"crossref","first-page":"428","DOI":"10.7326\/0003-4819-123-6-199509150-00006","article-title":"Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation","volume":"123","author":"Zhang","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.4065\/80.11.1517_bib103","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0889-8588(05)70201-X","article-title":"Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults","volume":"15","author":"Martin","year":"2001","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.4065\/80.11.1517_bib104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-115-1-13","article-title":"Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission","volume":"115","author":"Horowitz","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.4065\/80.11.1517_bib105","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0889-8588(05)70190-8","article-title":"Adult acute lymphocytic leukemia study testing chemotherapy and autolgous and allogeneic transplantation: a follow-up report of the French protocol LALA 87","volume":"14","author":"Thiebaut","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.4065\/80.11.1517_bib106","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1200\/JCO.2004.10.050","article-title":"Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial","volume":"22","author":"Thomas","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.11.1517_bib107","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood.V86.4.1619.bloodjournal8641619","volume":"86","author":"Attal","year":"1995","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib108","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1182\/blood-2004-08-3263","article-title":"Transplantation for adult ALL\u2014typing and timing","volume":"104","author":"Chauncey","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib109","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1182\/blood.V99.9.3151","article-title":"Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission","volume":"99","author":"Bunin","year":"2002","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib110","first-page":"481a","volume":"98","author":"Rowe","year":"2001","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib111","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1040-8428(98)00008-0","article-title":"The clinical significance of detection of residual disease in childhood ALL","volume":"28","author":"Faderl","year":"1998","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.4065\/80.11.1517_bib112","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0889-8588(05)70187-8","article-title":"Studies of minimal residual disease in acute lymphocytic leukemia","volume":"14","author":"Stock","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.4065\/80.11.1517_bib113","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/beha.2002.0229","article-title":"Risk-adapted treatment according to minimal residual disease in adult ALL","volume":"15","author":"G\u00f6kbuget","year":"2002","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.4065\/80.11.1517_bib114","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000077558","article-title":"Minimal residual disease in childhood acute lymphoblastic leukemia: current status and challenges","volume":"112","author":"Izraeli","year":"2004","journal-title":"Acta Haematol"},{"key":"10.4065\/80.11.1517_bib115","first-page":"146","article-title":"Detection of minimal residual disease in acute leukemia","volume":"18","author":"van der Velden","year":"2004","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.4065\/80.11.1517_bib116","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000077554","article-title":"Minimal residual disease studies by flow cytometry in acute leukemia","volume":"112","author":"Campana","year":"2004","journal-title":"Acta Haematol"},{"key":"10.4065\/80.11.1517_bib117","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1200\/JCO.20.4.1094","article-title":"Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia","volume":"20","author":"Mortuza","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.11.1517_bib118","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1182\/blood.V87.12.5251.bloodjournal87125251","article-title":"Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia","volume":"87","author":"Brisco","year":"1996","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib119","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/sj.leu.2400841","article-title":"Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response","volume":"11","author":"Foroni","year":"1997","journal-title":"Leukemia"},{"key":"10.4065\/80.11.1517_bib120","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/sj.leu.2400985","article-title":"Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome","volume":"12","author":"Gruhn","year":"1998","journal-title":"Leukemia"},{"key":"10.4065\/80.11.1517_bib121","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1200\/JCO.1998.16.11.3616","article-title":"Residual disease detection using fluorescent polymerase chain reaction at 20 weeks of therapy predicts clinical outcome in childhood acute lymphoblastic leukemia","volume":"16","author":"Evans","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.11.1517_bib122","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","article-title":"Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood","volume":"352","author":"van Dongen","year":"1998","journal-title":"Lancet"},{"key":"10.4065\/80.11.1517_bib123","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"339","author":"Cav\u00e9","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/80.11.1517_bib124","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1182\/blood.V99.6.1952","article-title":"Prognostic significance and modalities of flow cytometric minimal residual disease in acute lymphoblastic leukemia","volume":"99","author":"Dworzak","year":"2002","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib125","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood.V99.4.1253","article-title":"Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome","volume":"99","author":"Nyvold","year":"2002","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib126","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1182\/blood-2002-08-2613","article-title":"Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value","volume":"101","author":"Vidriales","year":"2003","journal-title":"Blood"},{"issue":"suppl 1","key":"10.4065\/80.11.1517_bib127","first-page":"S7","article-title":"DNA methylation changes in hematologic malignancies: biologic and clinical implications","volume":"11","author":"Issa","year":"1997","journal-title":"Leukemia"},{"key":"10.4065\/80.11.1517_bib128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0889-8588(05)70204-5","article-title":"Salvage therapy for refractory or relapsed acute lymphocytic leukemia","volume":"15","author":"Garcia-Manero","year":"2001","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.4065\/80.11.1517_bib129","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/sj.leu.2400861","article-title":"The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia","volume":"11","author":"Koller","year":"1997","journal-title":"Leukemia"},{"key":"10.4065\/80.11.1517_bib130","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1203::AID-CNCR15>3.0.CO;2-3","article-title":"Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia","volume":"86","author":"Aguayo","year":"1999","journal-title":"Cancer"},{"key":"10.4065\/80.11.1517_bib131","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1002\/1097-0142(19931001)72:7<2155::AID-CNCR2820720715>3.0.CO;2-V","article-title":"Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia","volume":"72","author":"Suki","year":"1993","journal-title":"Cancer"},{"key":"10.4065\/80.11.1517_bib132","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2003.04.031","article-title":"Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers","volume":"21","author":"Kantarjian","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.11.1517_bib133","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1182\/blood-2003-03-0925","article-title":"Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia","volume":"102","author":"Kantarjian","year":"2003","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib134","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood-2003-06-2122","article-title":"Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia","volume":"103","author":"Jeha","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib135","doi-asserted-by":"crossref","first-page":"196a","DOI":"10.1182\/blood.V104.11.684.684","article-title":"Phase II trials of clofarabine in relapsed or refractory pediatric leukemia [abstract]","volume":"104","author":"Jeha","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib136","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1200\/JCO.2005.03.426","article-title":"Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group","volume":"23","author":"Berg","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.11.1517_bib137","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.bmt.1701521","article-title":"FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission","volume":"22","author":"Deane","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.4065\/80.11.1517_bib138","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(87)92809-1","article-title":"Bone-marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second remission","volume":"1","author":"Herzig","year":"1987","journal-title":"Lancet"},{"key":"10.4065\/80.11.1517_bib139","first-page":"737","article-title":"Feasibility and timing of unrelated donor identification for patients with ALL","volume":"17","author":"Davies","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.4065\/80.11.1517_bib140","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","article-title":"Adult Burkitt leukemia and lymphoma","volume":"104","author":"Blum","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib141","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00001622-200409000-00003","article-title":"Treatment advances in adult Burkitt lymphoma and leukemia","volume":"16","author":"Kasamon","year":"2004","journal-title":"Curr Opin Oncol"},{"key":"10.4065\/80.11.1517_bib142","first-page":"109a","article-title":"Significance of CD20 positivity in de novo acute lymphocytic leukemia (ALL) [abstract]","volume":"96","author":"Thomas","year":"2000","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib143","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1200\/JCO.1999.17.8.2461","article-title":"Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia","volume":"17","author":"Thomas","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.4065\/80.11.1517_bib144","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1182\/blood-2002-03-0704","article-title":"Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia\u2014results of the prospective multicenter LALA-94 trial","volume":"100","author":"Dombret","year":"2002","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib145","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1182\/blood-2003-08-2958","article-title":"Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate","volume":"103","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib146","doi-asserted-by":"crossref","first-page":"748a","DOI":"10.1182\/blood.V104.11.2738.2738","article-title":"Update of the Hyper-CVAD and imatinib mesylate regimen in Philadelphia (Ph) positive acute lymphocytic leukemia (ALL) [abstract]","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib147","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1182\/blood-2004-04-1389","article-title":"Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia","volume":"104","author":"Towatari","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.11.1517_bib148","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ng1425","article-title":"Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia","volume":"36","author":"Graux","year":"2004","journal-title":"Nat Genet"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961161447X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961161447X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T12:25:48Z","timestamp":1709987148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561961161447X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":148,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S002561961161447X"],"URL":"https:\/\/doi.org\/10.4065\/80.11.1517","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}